BEAM THERAPEUTICS INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-1
Book Value Per Share
$13
Free Cash Flow Per Share
$-4
Cash Per Share
$3
Revenue Per Share
$1
OCF Per Share
$-3
Return on Equity
-8.1%
Return on Assets
-6.2%
Return on Invested Capital
-30.7%
Current Ratio
13.09
Quick Ratio
13.09
Asset Turnover
0.11
R&D / Revenue
293.1%
SBC / Revenue
67.4%
Capex / Revenue
10.7%
Working Capital
$1.17B
Net Current Asset Value
$1.03B
Invested Capital
$1.24B
OCF / Net Income
4.31
FCF / Net Income
4.50
Accruals Ratio (Sloan)
17.9%
Net Debt
$-1.25B
Net Debt / EBITDA
3.45
Capex Coverage
-23.09
Tangible Common Equity
$1.24B
TCE / Total Assets
83.6%
NOPAT
$-303M
Cash ROIC
-36.5%
WC / Revenue
838.5%
Capex / D&A
0.67
Reinvestment Rate
1.9%
Asset Growth vs Revenue Growth
-85.8%
Revenue 5Y CAGR
466.3%
Book Value 5Y CAGR
38.2%
Stock Price (FY-end)
$28
Market Cap
$2.74B
P/S Ratio
19.62
P/B Ratio
2.21
P/TB Ratio
2.21
P/OCF Ratio
—
Enterprise Value
$1.50B
EV / Sales
10.71
FCF Yield
-13.1%
Shareholder Yield
-3.4%
R&D Yield
14.9%
Capex Yield
0.5%
Shares Variation (YoY)
20.2%
Beta (5Y)
2.06
Cost of Equity
14.8%
52W High
$34
52W Low
$15
Trailing Return 1Y
4.2%
Trailing Return 5Y
-69.4%
F-Score (Piotroski)
3.00
Z-Score (Altman)
5.41
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.